Comparision The effect of premedication with Acifen and Dexamethasone on the success of mandible nerve block in first and second molar teeth of mandible with symptomatic irreversible pulpitis

Comparision The effect of premedication with Acifen and Dexamethasone on the success of inferior alveolar nerve block for first and second molar teeth with symptomatic irreversible pulpitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014082618941N1

Enrollment

150

Registered

2014-10-25

Start date

2014-11-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irrevesible pulpitis. Pulpitis

Interventions

Intervention 1: Dexamethasone group: .5 mg oral dexamethasone 30 minute before injection. Intervention 2: Acifen group: Acifen capsul contain 200 mg Iboprofen , 325 mg Acetaminophen, 40mg cofein 30 m

Treatment - Drugs

Dexamethasone group: .5 mg oral dexamethasone 30 minute before injection

Acifen group: Acifen capsul contain 200 mg Iboprofen , 325 mg Acetaminophen, 40mg cofein 30 minute befor injection

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: patient with first or second molar teeth of mandible with symptomatic irreversible pulpitis, non systematic disease, non allergic patient to Lidocaine with 1:80000 Epinephrine, non allergic patient to NSAIDs, non allergic patient to Caffeine, non periapical radiolucency, non analgesic drug consumption 12 hours before treatment, non tooth with full crown Exclusion criteria: non numles of lower lip, partial necrose of tooth

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 45 minutse before access cavity preparation and during access cavity preparation. Method of measurement: visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contact????? ?????

University of Medical Science

Fssfateme@gmail.com+98 28 3335 3061

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026